NASDAQ Companies

Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune®HPV in HPV16-Positive Head and Neck Cancer Conference call and webcast today at […]

HERZLIYA, Israel and BRISTOL, United Kingdom, March 27, 2025 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global […]

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP […]

Omaha, March 27, 2025 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife” or the “Company”) (Nasdaq: FTLF), a provider of innovative […]

            Record full-year 2024 HIFU revenue of USD 25.7 million, an increase of 15.3% over full-year […]

FLORHAM PARK, N.J., March 27, 2025 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage […]

HONG KONG, March 27, 2025 (GLOBE NEWSWIRE) — UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first […]

COCONUT CREEK, Fla., March 27, 2025 (GLOBE NEWSWIRE) — Air India Express (“AIX”), a wholly owned subsidiary of Air India, […]

HONG KONG, March 27, 2025 (GLOBE NEWSWIRE) — UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first […]

BEIJING, March 27, 2025 (GLOBE NEWSWIRE) — iQIYI, Inc. (Nasdaq: IQ) (“iQIYI” or the “Company”), a leading provider of online […]